COMPANY · NIPC 505792362

Overpharma, Lda

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €172,350,194.22 across 10,560 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameOverpharma, Lda
NIPC505792362
Registered office1070-073 Lisboa Lisboa
SourceTED (Jornal Oficial da UE), aviso 104744-2025
Record date17 February 2025

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €4,763,746.8220122013: €6,258,129.262014: €26,080,487.2320142015: €17,246,259.812016: €9,037,594.4020162017: €6,741,888.562018: €7,467,475.9520182019: €9,441,752.932020: €11,990,441.5620202021: €10,402,700.042022: €11,055,147.0620222023: €11,417,645.152024: €14,621,874.5920242025: €13,692,162.912026: €12,132,887.952026€26,080,487.23
Contracted value by year
YearContractsContract value
2012105€4,763,746.82
2013215€6,258,129.26
2014524€26,080,487.23
2015521€17,246,259.81
2016543€9,037,594.40
2017478€6,741,888.56
2018603€7,467,475.95
2019722€9,441,752.93
2020871€11,990,441.56
20211,028€10,402,700.04
2022858€11,055,147.06
20231,085€11,417,645.15
20241,216€14,621,874.59
2025929€13,692,162.91
2026862€12,132,887.95
Contracted value by place of performance
NameContractsContract value
Coimbra493€29,727,273.67
Lisboa1958€26,168,213.97
Faro622€25,534,367.31
Setúbal213€15,819,264.92
Évora190€11,062,751.89
Vila Nova de Gaia796€6,539,219.32
Portimão178€5,428,750.14
Lagos135€4,247,727.92
Porto567€4,073,525.88
Vila Real351€3,493,214.71
Largest contracts
SubjectYearContract value
CPA 2012/6 - Medicamentos do foro oncológico II2014€12,273,247.45
Medicamentos do Foro Oncológico2013€2,333,105.08
CP-AC-2020-019- CONCURSO PÚBLICO COM PUBLICAÇÃO NO JORNAL OFICIAL DA UNIÃO EUROPEIA PARA AQUISIÇÃO DE BATAS PARA SUPRIR NECESSIDADES NO ÂMBITO DO CONTEXTO EPIDEMIOLÓGICO DA DOENÇA RESPIRATÓRIA POR NOVO CORONAVÍRUS (2019-NCOV)2020€1,802,050
Correctivos da volémia e outras soluções estéreis2015€1,747,341.09
Medicamentos antiinfecciosos excepto antivíricos e antifúngicos - C/ Base no CPA 2013/52015€1,615,754.17

Who they competed with

In 37,912 contracts with a list of competitors, the company took part and was awarded 3,343 (9%).

Companies with the most procedures in common
CompanyProcedures in common
braun2,602
generis, sa2,110
labesfal-Laboratórios Almiro, SA1,967
farmoz, sa1,392
mylan1,385
medinfar1,384
sandoz farmaceutica1,348
hikma lda1,290
fresenius kabi pharma1,268
batist medical, lda1,089
anastacio saldanha, s.a.951
clinifar899
accord healthcare unipessoal, lda866
alloga858
hr845
pfizer801
Vygon,lda770
• MEDICINÁLIA CORMEDICA - COM. PROD. MEDICO HOSPITALARES, LDA755
medline international731
paul hartmann716
baxter medico708
bastos viegas, sa691
quilaban648
dla sa621
PRODUTOS MEDICO HOSPITALARES, S.A.602
medtronic portugal, lda564
ezequiel panão jorge561
teva pharma552
Normon, SA538
novartis517

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents43 companies and 60 links. The list below gives the same content as text.bastos viegas,… (NIPC 500042772)bastos viegas,…novartis (NIPC 500063524)novartispfizer (NIPC 500162166)pfizermedinfar (NIPC 500384045)medinfarlabesfal-Labor… (NIPC 501169580)labesfal-Labor…farmoz, sa (NIPC 501505334)farmoz, sabraun (NIPC 501506543)braunmylan (NIPC 502248793)mylanhikma lda (NIPC 502266791)hikma ldapaul hartmann (NIPC 502271728)paul hartmannOverpharma, Lda (NIPC 505792362)Overpharma, Lda+32 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.